These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14388361)

  • 1. [Extrapyramidal-like syndromes, oculogyral seizures and chlorpromazine].
    Letailleur M; Morin J; Demay J
    Ann Med Psychol (Paris); 1955 Apr; 113 1(4):639-45. PubMed ID: 14388361
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
    STECK H
    Encephale; 1956; 45(4):1083-9. PubMed ID: 13384342
    [No Abstract]   [Full Text] [Related]  

  • 3. [Extrapyramidal seizures caused by phenothiazine treatment].
    CONRAD K; DOMANOWSKY K; WIESER S
    Fortschr Neurol Psychiatr Grenzgeb; 1956 Sep; 24(9):505-12. PubMed ID: 13375763
    [No Abstract]   [Full Text] [Related]  

  • 4. [Psychomotor and extraphyramidal syndromes during prolonged chlorpromazine treatment].
    LAUNAY J; DESPAUTRE M
    Ann Med Psychol (Paris); 1956 Jul; 114(2):340-4. PubMed ID: 13340402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
    BOURGUIGNON A; DELAY J; DENIKER P; LEMPERIERE T
    Encephale; 1956; 45(4):1093-8. PubMed ID: 13384344
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical aspects of the syndrome of extrapyramidal behavior appearing during treatment by largactil].
    COLLIER G; DEFER B; LABORDE P
    J Med Bord; 1956 Mar; 133(3):255-63. PubMed ID: 13319968
    [No Abstract]   [Full Text] [Related]  

  • 7. [Extrapyramidal syndromes induced by chlorpromazine and reserpine].
    BOURGUIGNON A
    Sem Hop Ther Paris; 1960 Jul; 36():632-3. PubMed ID: 13803333
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute extrapyramidal accidents in the course of chlorpromazine treatment].
    MALLER O; CONSTANTINESCO GN
    Psychiatr Neurol (Basel); 1958 Mar; 135(3):176-89. PubMed ID: 13542669
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of tranquilizing drugs (reserpine, chlorpromazine) on extrapyramidal motility disorders].
    BRANDER E
    Monatsschr Psychiatr Neurol; 1956; 132(2-3):81-95. PubMed ID: 13369436
    [No Abstract]   [Full Text] [Related]  

  • 10. [Extrapyramidal and diencephalic syndrome in the course of largactil and serpasil treatments].
    STECK H
    Ann Med Psychol (Paris); 1954 Dec; 112(2 5):737-44. PubMed ID: 14362101
    [No Abstract]   [Full Text] [Related]  

  • 11. The implications of extrapyramidal symptoms in the treatment of schizophrenia.
    DENHAM J
    Rev Can Biol; 1961 Jun; 20():545-8. PubMed ID: 13885426
    [No Abstract]   [Full Text] [Related]  

  • 12. [Certain toxic manifestations during phenothiazine derivative therapy].
    TEMKOV I; BOIADZHIEVA M
    Suvr Med (Sofiia); 1957; 8(10):47-55. PubMed ID: 13569102
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical contribution to the knowledge of the extrapyramidal syndrome caused by neuroplegics].
    HANAU R
    Riv Patol Nerv Ment; 1963 Mar; 84():76-88. PubMed ID: 13952468
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationsip between the anti-hallucinatory effect and extrapyramidal symptoms induced by fluphenazine. (A study in 40 chronic schizophrenics).
    KRUSE W
    Curr Ther Res Clin Exp; 1961 Jan; 3():19-22. PubMed ID: 13754636
    [No Abstract]   [Full Text] [Related]  

  • 15. Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. II. Combined treatment with trifluoperazine-amobarbital.
    BRUNE GG; KOBAYASHI T; BULL C; TOURLENTES TT; HIMWICH HE
    Compr Psychiatry; 1962 Oct; 3():292-6. PubMed ID: 13873984
    [No Abstract]   [Full Text] [Related]  

  • 16. [EXTRAPYRAMIDAL SYNDROME WITH SUBINTRANT OCULOGYRIC CRISES DUE TO PROCHLORPEMAZINE THERAPY. APROPOS OF A CASE].
    MARZUOLI U; GRASSANO MC; RUBINO R
    Minerva Med; 1965 Jan; 56():87-90. PubMed ID: 14255783
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios.
    Sakalis G; Chan TL; Sathananthan G; Schooler N; Goldberg S; Gershon S
    Commun Psychopharmacol; 1977; 1(2):157-66. PubMed ID: 342185
    [No Abstract]   [Full Text] [Related]  

  • 18. Prien RF, Cole JO: High dose chlorpromazine therapy in chronic schizophrenia. Report of National Institute of Mental Health--psychopharmacology research branch collaborative study group.
    Arch Gen Psychiatry; 1968 Apr; 18(4):482-95. PubMed ID: 4868797
    [No Abstract]   [Full Text] [Related]  

  • 19. Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis.
    Swett C; Cole JO; Shapiro S; Slone D
    Arch Gen Psychiatry; 1977 Aug; 34(8):942-3. PubMed ID: 889418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizures occurring during intensive chlorpromazine therapy.
    SCHLICHTHER W; BRISTOW ME; SCHULTZ S; HENDERSON AL
    Can Med Assoc J; 1956 Mar; 74(5):364-6. PubMed ID: 13293612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.